Antivirals - A Broad Market Overview

TABLE OF CONTENTS

• Introduction 6
• Scope and coverage of the Brief 6
• Key findings about the antiviral market 7

CHAPTER 1 MARKET OVERVIEW 11

• The global antiviral market 11
• Key players 14

CHAPTER 2 DISEASE FOCUS 15

• Introduction 15
• HIV 15
• Disease overview 15
• Patient potential 16
• Market dynamics 18
• Current treatments 18
• Current market value and future focus 19
• Herpes 22
• HSV-1 and HSV-2 22
• Patient potential 23
• CMV 23
• Patient potential 24
• Market dynamics 25
• Hepatitis C 26
• Disease overview 26
• Patient potential 27
• Market dynamics 29
• Current treatment 29
• Future focus 30
• Hepatitis B 31
• Disease overview 31
• Patient potential 32
• Market dynamics 33
• Influenza 34
• Disease overview 34
• Patient potential 35
• Market dynamics 37
• RSV 38
• Disease overview 38
• Patient potential 38
• Market dynamics 39
• Summary 40
• Common drivers of antiviral market growth 40
• Common limits to market growth 41

CHAPTER 3 FUTURE FOCUS 43

• Research and development 43
• Life-cycle and portfolio management 44
• Case study: lamivudine life-cycle management 45
• Portfolio design 45

APPENDIX 47

• Bibliography 47
• Websites 50
• Market attractiveness matrix methodology 52
• Disclaimer 55